Individualized dosing guidelines for PEGasparaginase and factors influencing the clearance: a population pharmacokinetic model

Mostrar otras versiones (1)
Detalles Bibliográficos
Autores principales: Kloos, Robin Q.H., Mathôt, Ron, Pieters, Rob, van der Sluis, Inge M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2023
Materias:
Errata Corrige
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483340/
https://www.ncbi.nlm.nih.gov/pubmed/37317924
http://dx.doi.org/10.3324/haematol.2023.283685
_version_ 1785102353835229184
author Kloos, Robin Q.H.
Mathôt, Ron
Pieters, Rob
van der Sluis, Inge M.
author_facet Kloos, Robin Q.H.
Mathôt, Ron
Pieters, Rob
van der Sluis, Inge M.
author_sort Kloos, Robin Q.H.
collection PubMed
description
format Online
Article
Text
id pubmed-10483340
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Fondazione Ferrata Storti
record_format MEDLINE/PubMed
spelling pubmed-104833402023-09-08 Individualized dosing guidelines for PEGasparaginase and factors influencing the clearance: a population pharmacokinetic model Kloos, Robin Q.H. Mathôt, Ron Pieters, Rob van der Sluis, Inge M. Haematologica Errata Corrige Fondazione Ferrata Storti 2023-06-15 /pmc/articles/PMC10483340/ /pubmed/37317924 http://dx.doi.org/10.3324/haematol.2023.283685 Text en Copyright© 2023 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Errata Corrige
Kloos, Robin Q.H.
Mathôt, Ron
Pieters, Rob
van der Sluis, Inge M.
Individualized dosing guidelines for PEGasparaginase and factors influencing the clearance: a population pharmacokinetic model
title Individualized dosing guidelines for PEGasparaginase and factors influencing the clearance: a population pharmacokinetic model
title_full Individualized dosing guidelines for PEGasparaginase and factors influencing the clearance: a population pharmacokinetic model
title_fullStr Individualized dosing guidelines for PEGasparaginase and factors influencing the clearance: a population pharmacokinetic model
title_full_unstemmed Individualized dosing guidelines for PEGasparaginase and factors influencing the clearance: a population pharmacokinetic model
title_short Individualized dosing guidelines for PEGasparaginase and factors influencing the clearance: a population pharmacokinetic model
title_sort individualized dosing guidelines for pegasparaginase and factors influencing the clearance: a population pharmacokinetic model
topic Errata Corrige
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483340/
https://www.ncbi.nlm.nih.gov/pubmed/37317924
http://dx.doi.org/10.3324/haematol.2023.283685
work_keys_str_mv AT kloosrobinqh individualizeddosingguidelinesforpegasparaginaseandfactorsinfluencingtheclearanceapopulationpharmacokineticmodel
AT mathotron individualizeddosingguidelinesforpegasparaginaseandfactorsinfluencingtheclearanceapopulationpharmacokineticmodel
AT pietersrob individualizeddosingguidelinesforpegasparaginaseandfactorsinfluencingtheclearanceapopulationpharmacokineticmodel
AT vandersluisingem individualizeddosingguidelinesforpegasparaginaseandfactorsinfluencingtheclearanceapopulationpharmacokineticmodel

Ejemplares similares